The civic record
Read. Follow. Verify.Kentucky legislature establishes terminal distributor permits and broadens drug safety oversight in Jimmie's Law
Last action · March 4, 2026: to Licensing, Occupations, & Administrative Regulations (H)Sponsors: Vanessa Grossl and 2 others
Track this bill to get notified when it advances a stage. One tap to stop, anytime.
What This Bill Proposed
Kentucky enacts Jimmie's Law to strengthen pharmaceutical drug safety by requiring s of prescription drugs to obtain a board permit starting January 1, 2027, establishing strict and adverse event reporting rules, and declaring an emergency for immediate implementation upon passage.
The measure introduces mandatory state permitting for s and new reporting duties for adverse events, altering operational compliance for entities handling prescription drugs within Kentucky and establishing criminal penalties for unauthorized drug transfers.
- The Kentucky General Assembly regularly updates pharmaceutical regulations under KRS Chapter 315 to ensure drug safety and oversee practitioners and pharmacies. context
Who It Would Have Affected
Groups the bill's text would have affected, as described in the record. Being affected is not a position for or against it.
Terminal distributors of prescription drugs
Entities possessing, holding, or procuring prescription drugs must obtain a separate permit for each location starting January 1, 2027, and comply with board inspection and safety rules.
Pharmacies and Pharmacists
Pharmacies face new reporting timelines for serious adverse events, stricter compounding guidelines under USP standards, and restrictions on drug purchasing sources.
Kentucky Board of Pharmacy
The board receives expanded regulatory and inspection authority over terminal distributors, new reporting requirements to professional licensing boards, and mandates to submit annual reports to the Legislative Research Commission.
Key Facts
You don't have to trust us. Each fact below is taken straight from the official document - click any one to see the exact passage, highlighted in the original.
Frequently Asked Questions
What must pharmacies do if they become aware of a serious adverse event?
Who is exempt from obtaining a terminal distributor permit?
What else do you want to know?
News Coverage
Follow the record
Votes, people, money & the original sourceWhere This Stands
This bill did not become law - Died at adjournment · in House committee.
Procedural history
2 actions- Mar 4, 2026HouseCommitteeto Licensing, Occupations, & Administrative Regulations (H)
- Feb 25, 2026HouseIntroducedintroduced in House to Committee on Committees (H)
Version history
Only one version on file - nothing to compare yet. As later stages (committee substitute, engrossed, enrolled) are captured, the redline appears here.
View official text →Lobbying Activity
No state lobbying filings in our records match this bill. Federal lobbying reports (LDA) cover Congress, so they are not listed on state bills.
Full breakdown
Who this bill affects and the strongest case for and against it, written only from the bill’s own text.
Sponsors
Discoveries
Patterns POLISCOPE noticed across the record. These are observations to investigate, not conclusions.
Mandatory Terminal Distributor Permitting
Kentucky is extending formal permit requirements to terminal distributors of prescription drugs with an enforcement deadline of January 1, 2027.
Connected Entities
Sources
apps.legislature.ky.gov
Analysis Score
0–100- Significance20Lowered because this bill did not pass (its text scored 85)
- Controversy25Intensity of disagreement among stakeholders
- Entertainment5Compellingness for a non-policy-wonk reader
- Buzz30Current news / social attention level
Publisher tools